findmyKOL

Shailaja Hayden, MD

Basic profile

The University of Texas at Austin

ORCIDNone on fileNPI
RegionAustin, TX · South CentralSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Shailaja Hayden is a Respiratory physician affiliated with The University of Texas at Austin. OpenAlex indexes 7 publications with 290 citations (h-index 3).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

290citations

Total citations across indexed works.

3h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1301 W 38th St Ste 700
Austin, TX 787051016

Telephone

512-324-3340

Provider last certified this registry record 14 Jun 2021.

View the NPPES registry record

Industry payments

7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    42.5%
    Kinase inhibitor35.1%
    Ofev100%
    Part D<11 patients
    Pyridone7.5%
    Pirfenidone100%
    Part D<11 patients
  • Respiratory

    39.7%
    beta2-Adrenergic Agonist16.1%
    Albuterol Sulfate Hfa100%
    Part D13 patients
    Leukotriene Receptor Antagonist13.2%
    Montelukast Sodium100%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    10.3%
    Corticosteroid10.3%
    Prednisone100%
    Part D<11 patients
Where care is delivered (Part B)36.2% facility · 63.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”